Therefore, we studied the changes in the expression levels of the above targets to verify whether HJJPD plays a role in the treatment of simple obesity through the JAK2-STAT3 pathway (Table 4). The gene discussed is STAT3; the disease is obesity due to melanocortin 4 receptor deficiency.